GMA
Weekly Intelligence · 3 August 2026
News, science andAI toolsfor nutraceuticals.
Verified updates, market data and technologies for understanding the scientific and industrial evolution of food supplements.
03 Aug 2026 · GeNeurofil™ and cognitive decline: a clinical signal that needs confirmation.03 Aug 2026 · Probiotics and weight cutting: what the new trial teaches developers.03 Aug 2026 · From paper to shortlist: how LLMs can accelerate strain scouting.03 Aug 2026 · Innovative botanicals: the challenge is moving from bioactivity to transferability.03 Aug 2026 · Multi-ingredient formulas: evidence is shifting towards the finished product.02 Aug 2026 · Food additives: EFSA’s dossier architecture changed on 20 July.02 Aug 2026 · L-α-GPC: EFSA opens a regulatory route, not a cognitive claim.02 Aug 2026 · Microalgal DHA: without conclusive strain identity, the dossier stops.02 Aug 2026 · EFSA’s botanical Compendium: a screening tool, not a blacklist.02 Aug 2026 · LLMs and nutraceutical biosynthesis: from literature to candidate strains.01 Aug 2026 · New micronutrient sources: EFSA updates the assessment framework.01 Aug 2026 · Emerging ingredients: EFSA surveillance becomes a scouting tool.01 Aug 2026 · AI and functional foods: from bioactive discovery to manufacturing.01 Aug 2026 · Explainable AI: making bioactive and formulation predictions legible.01 Aug 2026 · L-α-GPC from soy lecithin: EFSA concludes its Novel Food safety review.31 Jul 2026 · NR and pterostilbene in menopause: a pilot that helps frame the question.31 Jul 2026 · CRL1505: building a probiotic dossier without losing the strain.31 Jul 2026 · Multi-ingredient formulas: from bioavailability to proof of the finished product.31 Jul 2026 · Generative AI attempts to turn formulation into inverse design.31 Jul 2026 · Hair wellness: from a single ingredient to a biological system that needs evidence.30 Jul 2026 · Koncentra: from global commercialisation to formulation proof.30 Jul 2026 · AG1: bioavailability becomes an experimental question for complex formulas.30 Jul 2026 · CRL1505: the value of the evidence remains tied to the studied strain.30 Jul 2026 · EFSA emerging risks: a checklist for ingredient scouting.30 Jul 2026 · Personalised nutrition: validation will define the difference.29 Jul 2026 · Emerging risks in food supplements: how to read the new European report.29 Jul 2026 · A molecular “timer” records sleep duration and fragmentation in mice.29 Jul 2026 · Genesis Mission: AI funding moves from strategy to its first projects.29 Jul 2026 · Diet, health and environment: national averages conceal decisive differences.29 Jul 2026 · Independent batch testing is becoming a competitive signal.03 Aug 2026 · GeNeurofil™ and cognitive decline: a clinical signal that needs confirmation.03 Aug 2026 · Probiotics and weight cutting: what the new trial teaches developers.03 Aug 2026 · From paper to shortlist: how LLMs can accelerate strain scouting.03 Aug 2026 · Innovative botanicals: the challenge is moving from bioactivity to transferability.03 Aug 2026 · Multi-ingredient formulas: evidence is shifting towards the finished product.02 Aug 2026 · Food additives: EFSA’s dossier architecture changed on 20 July.02 Aug 2026 · L-α-GPC: EFSA opens a regulatory route, not a cognitive claim.02 Aug 2026 · Microalgal DHA: without conclusive strain identity, the dossier stops.02 Aug 2026 · EFSA’s botanical Compendium: a screening tool, not a blacklist.02 Aug 2026 · LLMs and nutraceutical biosynthesis: from literature to candidate strains.01 Aug 2026 · New micronutrient sources: EFSA updates the assessment framework.01 Aug 2026 · Emerging ingredients: EFSA surveillance becomes a scouting tool.01 Aug 2026 · AI and functional foods: from bioactive discovery to manufacturing.01 Aug 2026 · Explainable AI: making bioactive and formulation predictions legible.01 Aug 2026 · L-α-GPC from soy lecithin: EFSA concludes its Novel Food safety review.31 Jul 2026 · NR and pterostilbene in menopause: a pilot that helps frame the question.31 Jul 2026 · CRL1505: building a probiotic dossier without losing the strain.31 Jul 2026 · Multi-ingredient formulas: from bioavailability to proof of the finished product.31 Jul 2026 · Generative AI attempts to turn formulation into inverse design.31 Jul 2026 · Hair wellness: from a single ingredient to a biological system that needs evidence.30 Jul 2026 · Koncentra: from global commercialisation to formulation proof.30 Jul 2026 · AG1: bioavailability becomes an experimental question for complex formulas.30 Jul 2026 · CRL1505: the value of the evidence remains tied to the studied strain.30 Jul 2026 · EFSA emerging risks: a checklist for ingredient scouting.30 Jul 2026 · Personalised nutrition: validation will define the difference.29 Jul 2026 · Emerging risks in food supplements: how to read the new European report.29 Jul 2026 · A molecular “timer” records sleep duration and fragmentation in mice.29 Jul 2026 · Genesis Mission: AI funding moves from strategy to its first projects.29 Jul 2026 · Diet, health and environment: national averages conceal decisive differences.29 Jul 2026 · Independent batch testing is becoming a competitive signal.
News, data and
innovative tools
for today’s professionals.
01 / WeeklyThis week’s intelligence
5 updates on nutraceuticals, science and AI · 3 August 2026.
Open the briefing → 02 / MarketUSD 683.8 bn2026 estimate for the global nutraceutical market.
Explore the data → 03 / DossierBerberine beyond the metabolic hypeIdentity, evidence, dose, formulation, safety and European attention.
Read the dossier → 04 / RegulatoryInstitutional sources, monitoredNovel Foods, botanicals, claims, safety and quality.
Read the updates → 05 / AI LabOne applied project every weekDemonstration cases across research, concepts, formulation and industrial work.
Explore the weekly case →Briefing & AI advisory
From news
to application.
Receive the editorial selection or request a free introductory conversation on using AI tools and automation in nutraceutical work.
Selected newsFree consultationAI & automation